CNCR vs. BITQ
Compare and contrast key facts about Loncar Cancer Immunotherapy ETF (CNCR) and Bitwise Crypto Industry Innovators ETF (BITQ).
CNCR and BITQ are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CNCR is a passively managed fund by Exchange Traded Concepts that tracks the performance of the Loncar Cancer Immunotherapy Index. It was launched on Oct 13, 2015. BITQ is a passively managed fund by Exchange Traded Concepts that tracks the performance of the Bitwise Crypto Innovators 30 Total Return. It was launched on May 11, 2021. Both CNCR and BITQ are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
CNCR vs. BITQ - Performance Comparison
Loading graphics...
CNCR vs. BITQ - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
BITQ Bitwise Crypto Industry Innovators ETF | -2.29% |
Returns By Period
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BITQ
- 1D
- -0.58%
- 1M
- -8.31%
- YTD
- -5.92%
- 6M
- -26.36%
- 1Y
- 47.29%
- 3Y*
- 48.40%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CNCR vs. BITQ - Expense Ratio Comparison
CNCR has a 0.79% expense ratio, which is lower than BITQ's 0.85% expense ratio.
Return for Risk
CNCR vs. BITQ — Risk / Return Rank
CNCR
BITQ
CNCR vs. BITQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Bitwise Crypto Industry Innovators ETF (BITQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| CNCR | BITQ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 0.81 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.05 | — |
Dividends
CNCR vs. BITQ - Dividend Comparison
Neither CNCR nor BITQ has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BITQ Bitwise Crypto Industry Innovators ETF | 0.00% | 0.00% | 0.90% | 1.51% | 0.00% | 3.12% |
Drawdowns
CNCR vs. BITQ - Drawdown Comparison
The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum BITQ drawdown of -90.32%. Use the drawdown chart below to compare losses from any high point for CNCR and BITQ.
Loading graphics...
Drawdown Indicators
| CNCR | BITQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -90.32% | +90.32% |
Max Drawdown (1Y)Largest decline over 1 year | — | -44.99% | — |
Current DrawdownCurrent decline from peak | 0.00% | -42.16% | +42.16% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -53.86% | +53.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 19.87% | — |
Volatility
CNCR vs. BITQ - Volatility Comparison
Loading graphics...
Volatility by Period
| CNCR | BITQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 17.63% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 45.99% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 58.97% | -58.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 67.77% | -67.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 67.77% | -67.77% |